NCT01472315View on ClinicalTrials.gov

Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions
Sleep Apnea
Interventions
DRUG

medroxyprogesterone acetate

MPA hormone therapy 30mg two hours before bedtime and 30mg right before going to bed every night for two weeks period

DRUG

Placebo

Placebo pills were taken in same way as active comparator

Trial Locations (1)

20520

Sleep Research Unit, Department of Physiology, Turku University, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT01472315 - Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities | Biotech Hunter | Biotech Hunter